These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24024153)

  • 41. Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure.
    Linsdell P
    Channels (Austin); 2018; 12(1):284-290. PubMed ID: 30152709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cystic fibrosis modifying genes].
    Knauer N; Ratjen F; Grasemann H
    Pneumologie; 2005 Jun; 59(6):395-404. PubMed ID: 15991075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cystic Fibrosis and the Nervous System.
    Reznikov LR
    Chest; 2017 May; 151(5):1147-1155. PubMed ID: 27876591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.
    Melin P; Thoreau V; Norez C; Bilan F; Kitzis A; Becq F
    Biochem Pharmacol; 2004 Jun; 67(12):2187-96. PubMed ID: 15163550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME
    Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding how cystic fibrosis mutations cause a loss of Cl- channel function.
    Sheppard DN; Ostedgaard LS
    Mol Med Today; 1996 Jul; 2(7):290-7. PubMed ID: 8796909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystic Fibrosis: Pathophysiology of Lung Disease.
    Bergeron C; Cantin AM
    Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unmet needs in cystic fibrosis.
    Rubin BK
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):49-52. PubMed ID: 30063865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells.
    Mohamed A; Ferguson D; Seibert FS; Cai HM; Kartner N; Grinstein S; Riordan JR; Lukacs GL
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):259-65. PubMed ID: 9078271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
    Zhang S; Shrestha CL; Kopp BT
    Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function.
    Trouvé P; Le Drévo MA; Kerbiriou M; Friocourt G; Fichou Y; Gillet D; Férec C
    Biochim Biophys Acta; 2007 Oct; 1772(10):1121-33. PubMed ID: 17869070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytoskeleton and CFTR.
    Edelman A
    Int J Biochem Cell Biol; 2014 Jul; 52():68-72. PubMed ID: 24685681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis.
    Kraus C; Reis A; Naehrlich L; Dötsch J; Korbmacher C; Rauh R
    Cell Physiol Biochem; 2007; 19(5-6):239-48. PubMed ID: 17495464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.
    Zhang W; Fujii N; Naren AP
    Future Med Chem; 2012 Mar; 4(3):329-45. PubMed ID: 22393940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.